Spire Healthcare, a leading private hospital group, is delighted to announce it has been granted planning permission to develop a major new cancer centre next to Baddow Hospital in Chelmsford, Essex.
Work will begin immediately with completion expected towards the end of 2015. The plans include a two-storey centre with a two-bunker radiotherapy facility. The facility will house two state-of-the-art linear accelerators (LinAcs), a wide-bore CT scanner, consultant offices and consulting rooms and an eight bay chemotherapy suite.
The centre follows the success of Spire’s Specialist Care Centre in Bristol. It will be conveniently situated in the heart of Essex near key motorway and major road links and will utilise state-of-the-art planning and treatment techniques to provide patients with the most technically advanced treatment, partnered with high standards of patient care and support. It will treat a broad range of cancers, including breast, prostate and lung cancers, and will enable Spire to offer integrated end-to-end care for patients from diagnosis right through to recovery.
Neil McCullough, Spire’s Group Development Director, said: “For many cancer sufferers, the opportunity to have end to end care, from diagnosis right through to recovery, from the same provider is incredibly important. We are thrilled to be able to bring this service to a new region and support this centre for Essex and the surrounding areas.” Whilst the centre is aimed initially at treating insured and self-paying patients, we hope that commissioners will take advantage of a local solution and include our centre as an option for NHS patients.
Radiotherapy is a highly effective way of treating cancer, yet remains undersupplied in the NHS with just 5.2 LinAcs per million of population – a figure some way below the rest of the major European countries. This development will bring a welcome increase to the country’s private provision of LinAcs – especially outside of London, which currently stands at only 20 private machines nationwide.